Patents by Inventor Gail Mandel

Gail Mandel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR EDITING RNA
    Publication number: 20200291383
    Abstract: Compositions and methods for editing endogenous RNA molecules are provided.
    Type: Application
    Filed: October 9, 2018
    Publication date: September 17, 2020
    Inventors: Gail MANDEL, John P. ADELMAN, John SINNAMON
  • Peripheral nervous system specific sodium channel nucleic acids
    Patent number: 8012748
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analyzing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: September 6, 2011
    Assignee: The Research Foundation of State University of New York
    Inventors: Gail Mandel, Simon Halegoua
  • Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
    Publication number: 20090203122
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Application
    Filed: June 6, 2007
    Publication date: August 13, 2009
    Applicant: The Research Foundation of State University of New York
    Inventors: Gail Mandel, Simon Halegoua
  • Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
    Publication number: 20090029415
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Application
    Filed: June 6, 2007
    Publication date: January 29, 2009
    Applicant: The Research Foundation of State University of New York
    Inventors: Gail Mandel, Simon Halegoua
  • Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
    Publication number: 20040229792
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Application
    Filed: January 29, 2004
    Publication date: November 18, 2004
    Applicants: The Research Foundation of State University of New York, The SUNY at Stony Brook, ICAgen, Inc. (Allelix cases)
    Inventors: Gail Mandel, Simon Halegoua
  • Peripheral nervous system specific sodium channels
    Patent number: 6703486
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: March 9, 2004
    Assignee: Research Foundation of State University of New York, The SUNY at Stony Brook
    Inventors: Gail Mandel, Simon Halegoua, Laurence A. Borden
  • PERIPHERAL NERVOUS SYSTEM SPECIFIC SODIUM CHANNELS, DNA ENCODING THEREFOR CRYSTALLIZATION, X-RAY DIFFRACTION, COMPUTER MOLECULAR MODELING, RATIONAL DRUG DESIGN, DRUG SCREENING, AND METHODS OF MAKING AND USING THEREOF
    Publication number: 20030092645
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Application
    Filed: December 9, 1999
    Publication date: May 15, 2003
    Inventors: GAIL MANDEL, SIMON HALEGOUA
  • Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
    Patent number: 6110672
    Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.
    Type: Grant
    Filed: May 2, 1997
    Date of Patent: August 29, 2000
    Assignee: Research Foundation of State University of New York, The SUNY at Stony Brook
    Inventors: Gail Mandel, Simon Halegoua